NASDAQ · Biotechnology

IDEAYA Biosciences, Inc. (IDYA) Stock

$36.06 -0.55% NASDAQ: IDYA Healthcare

Valuation

MetricValue
Price$36.06
Market Cap$3.43B
P/E Ratio-19.46
P/B Ratio2.87
P/S Ratio15.17
EPS (TTM)$-1.28
52-Week High$42.68
52-Week Low$26.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.47%
ROA-13.36%
ROCE-17.68%
Gross Margin-72.60%
Operating Margin-72.60%
Net Margin-74.75%
Debt/Equity0.02
Current Ratio11.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$28.0M$51.0M$23.0M$7.0M$219.0M
Operating Profit$-50.0M$-63.0M$-134.0M$-327.0M$-159.0M
Net Profit$-50.0M$-59.0M$-113.0M$-274.0M$-114.0M
EPS$-1.41$-1.42$-1.96$-3.36$-1.28
Op Margin-179.9%-122.7%-574.9%-4671.1%-72.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$381.0M$388.0M$649.0M$1.1B$1.1B
Total Liabilities$80.0M$39.0M$28.0M$65.0M$86.0M
Cash$92.0M$69.0M$157.0M$84.0M$113.0M
Borrowings$5.0M$3.0M$3.0M$19.0M$28.0M

Latest News

Ideaya Biosciences Insider Sold Shares Worth $382,131, According to a Recent SEC Filing MT Newswires · Jul 9, 2026 RBC Capital Adjusts IDEAYA Biosciences Price Target to $48 From $53, Maintains Outperform Rating MT Newswires · Jul 7, 2026 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire · Jun 26, 2026 IDEAYA Biosciences Elects CEO Yujiro Hata as Chairman MT Newswires · Jun 17, 2026 IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors PR Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-56.0M$-87.0M$-115.0M$-248.0M$-71.0M
Investing Cash Flow$-72.0M$-37.0M$-161.0M$-506.0M$68.0M
Financing Cash Flow$2.0M$2.0M$11.0M$14.0M$0
Net Cash Flow$20.0M$-23.0M$89.0M$-73.0M$28.0M
Free Cash Flow$-58.0M$-91.0M$-118.0M$-251.0M$-73.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.99
EV / EBITDA-15.57
FCF Yield-3.21%
Quick Ratio10.45
Interest Coverage0.00
Return 1Y60.89%
Return 3Y40.98%
Return 5Y82.24%

Ownership

Insiders Held2.22%
Institutions Held101.90%
Institutions Float Held104.22%
Institutional HolderSharesReport Date
FMR, LLC13,172,1032026-03-31
Blackrock Inc.8,442,1332026-03-31
Janus Henderson Group PLC7,265,2532026-03-31
Capital Research Global Investors5,163,5432026-03-31
Baker Bros. Advisors, LP3,946,5152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COGTCogent Biosciences, Inc. $30.08 -0.20% -13.36 $5.14B 0.00%
ERASErasca, Inc. $15.46 +9.49% -15.52 $5.37B 0.00%
FHTXFoghorn Therapeutics Inc. $1.99 -4.78% -2.11 $116.84M 0.00%
NRIXNurix Therapeutics, Inc. $22.21 -2.29% -6.61 $2.30B 0.00%
PRLDPrelude Therapeutics Incorporated $3.88 +1.31% -4.65 $220.90M 0.00%

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. (IDYA) stock trades at $36.06 with a market capitalization of $3.43B. The stock is valued at a price-to-earnings (P/E) ratio of -19.46, price-to-book of 2.87, price-to-sales of 15.17. Over the past 52 weeks the stock has ranged between $26.05 and $42.68, and currently trades 15.5% below its 52-week high.

On profitability, IDEAYA Biosciences, Inc. generates a return on equity (ROE) of -16.47%, return on capital employed of -17.68%, an operating margin of -72.60%, a net profit margin of -74.75%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides